Clinical trial
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Dose-Regimen Study of the Efficacy and Safety of TOLAMBA™ in Ragweed-Allergic Rhinitis Adults
NCT00387738 is registered in ClinicalTrials.gov with Dynavax Technologies Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Dose-Regimen Study of the Efficacy and Safety of TOLAMBA™ in Ragweed-Allergic Rhinitis Adults
- Lead sponsor
- Dynavax Technologies Corporation
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 30, 2006
- Completion date
- March 31, 2008
- Enrollment
- 738 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.